Acurx Pharmaceuticals (ACXP) Misses Q1 EPS by 4c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q1 EPS of ($0.28), $0.04 worse than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00